MK
ABBV icon

MASTERINVEST Kapitalanlage’s AbbVie ABBV Stock Holding History

MASTERINVEST Kapitalanlage’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.1M Sell
73,881
-8,675
-11% -$1.92M 1.67% 11
2025
Q4 		$19M Sell
82,556
-82
-0.1% -$18.7K 1.8% 10
2025
Q3 		$19.1M Buy
82,638
+16,005
+24% +$3.26M 1.87% 10
2025
Q2 		$12.4M Buy
+66,633
New +$12.4M 1.3% 14

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MASTERINVEST Kapitalanlage's ABBV Position: Q1 2026 in Review

MASTERINVEST Kapitalanlage reduced its AbbVie (ABBV) stake by 11% in Q1 2026, selling an estimated $1.92M and leaving 73,881 shares worth $16.1M. The position accounts for 1.67% of the portfolio, ranked #11.

MASTERINVEST Kapitalanlage first reported a position in ABBV in Q2 2025 and has held it in 4 quarters since. The position peaked at $19.1M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • MASTERINVEST Kapitalanlage held 73,881 shares of AbbVie worth $16.1M as of Q1 2026.
  • MASTERINVEST Kapitalanlage sold 8,675 AbbVie shares in Q1 2026, an estimated $1.92M.
  • AbbVie made up 1.67% of MASTERINVEST Kapitalanlage's portfolio in Q1 2026, its #11 holding.
  • MASTERINVEST Kapitalanlage first reported a position in AbbVie in Q2 2025 and has held it in 4 quarters since.
  • MASTERINVEST Kapitalanlage's AbbVie position peaked at $19.1M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MASTERINVEST Kapitalanlage's 13F filing for Q1 2026, filed 5 May 2026.